Gene · 4547
Papers2,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pancreas-Liver-Adipose Axis: Target of Environmental Cadmium Exposure Linked to Metabolic Diseases. | Toxics | 2023 | 36976988 | PubTator, text mining | PubMed |
| Genomic analysis of lean individuals with NAFLD identifies monogenic disorders in a prospective cohort study. | JHEP Rep | 2023 | 36937991 | PubTator, text mining | PubMed |
| Incidence of acute pancreatitis among patients with leptospirosis requiring extracorporeal membrane oxygenation (ECMO): a descriptive study. | BMJ Open Gastroenterol | 2023 | 36927735 | PubTator, text mining | PubMed |
| New insights into the inter-organ crosstalk mediated by ChREBP. | Front Endocrinol (Lausanne) | 2023 | 36923222 | PubTator, text mining | PubMed |
| New CRISPR Technology for Creating Cell Models of Lipoprotein Assembly and Secretion. | Curr Atheroscler Rep | 2023 | 36913170 | PubTator, text mining | PubMed |
Unveiling the therapeutic potential of cabozantinib-loaded poly D,L-lactic-co-glycolic acid and polysarcosine nanoparticles in inducing apoptosis and cytotoxicity in human HepG2 hepatocellular carcinoma cell lines and in vivo anti-tumor activity in SCID female mice. | Front Oncol | 2023 | 36874145 | PubTator, text mining | PubMed |
| Rapamycin suppresses inflammation and increases the interaction between p65 and IκBα in rapamycin-induced fatty livers. | PLoS One | 2023 | 36867603 | PubTator, text mining | PubMed |
| Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice. | Signal Transduct Target Ther | 2023 | 36864030 | PubTator, text mining | PubMed |
| Phytosterols and Cardiovascular Risk Evaluated against the Background of Phytosterolemia Cases-A German Expert Panel Statement. | Nutrients | 2023 | 36839186 | PubTator, text mining | PubMed |
| The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma. | Molecules | 2023 | 36838613 | PubTator, text mining | PubMed |
| Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators. | Life (Basel) | 2023 | 36836874 | PubTator, text mining | PubMed |
| Pre-Diabetes-Linked miRNA miR-193b-3p Targets PPARGC1A, Disrupts Metabolic Gene Expression Profile and Increases Lipid Accumulation in Hepatocytes: Relevance for MAFLD. | Int J Mol Sci | 2023 | 36835287 | PubTator, text mining | PubMed |
| Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges. | Int J Mol Sci | 2023 | 36834701 | PubTator, text mining | PubMed |
| Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis. | Int J Mol Sci | 2023 | 36834635 | PubTator, text mining | PubMed |
| Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis. | Biomedicines | 2023 | 36830921 | PubTator, text mining | PubMed |
| Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. | Biomedicines | 2023 | 36830808 | PubTator, text mining | PubMed |
| Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines. | Antioxidants (Basel) | 2023 | 36830074 | PubTator, text mining | PubMed |
| Network Pharmacological Analysis of a New Herbal Combination Targeting Hyperlipidemia and Efficacy Validation In Vitro. | Curr Issues Mol Biol | 2023 | 36826031 | PubTator, text mining | PubMed |
| Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. | Nat Biotechnol | 2023 | 36823355 | PubTator, text mining | PubMed |
| Osteoprotegerin deficiency aggravates methionine-choline-deficient diet-induced nonalcoholic steatohepatitis in mice. | Sci Rep | 2023 | 36823220 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4547/papers?page=15